149 related articles for article (PubMed ID: 37452976)
1. Inhibition of FEN1 promotes DNA damage and enhances chemotherapeutic response in prostate cancer cells.
Wang Z; Yong C; Fu Y; Sun Y; Guo Z; Liu SB; Hu Z
Med Oncol; 2023 Jul; 40(8):242. PubMed ID: 37452976
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor knockdown enhances prostate cancer chemosensitivity by down-regulating FEN1 through the ERK/ELK1 signalling pathway.
Xie W; Li S; Guo H; Zhang J; Tu M; Wang R; Lin B; Wu Y; Wang X
Cancer Med; 2023 Jul; 12(14):15317-15336. PubMed ID: 37326412
[TBL] [Abstract][Full Text] [Related]
3. Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.
He L; Zhang Y; Sun H; Jiang F; Yang H; Wu H; Zhou T; Hu S; Kathera CS; Wang X; Chen H; Li H; Shen B; Zhu Y; Guo Z
EBioMedicine; 2016 Dec; 14():32-43. PubMed ID: 27852524
[TBL] [Abstract][Full Text] [Related]
4. FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer.
He L; Luo L; Zhu H; Yang H; Zhang Y; Wu H; Sun H; Jiang F; Kathera CS; Liu L; Zhuang Z; Chen H; Pan F; Hu Z; Zhang J; Guo Z
Mol Oncol; 2017 Jun; 11(6):640-654. PubMed ID: 28371273
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer.
Lu X; Liu R; Wang M; Kumar AK; Pan F; He L; Hu Z; Guo Z
Oncogene; 2020 Jan; 39(1):234-247. PubMed ID: 31471584
[TBL] [Abstract][Full Text] [Related]
6. FEN1 endonuclease as a therapeutic target for human cancers with defects in homologous recombination.
Guo E; Ishii Y; Mueller J; Srivatsan A; Gahman T; Putnam CD; Wang JYJ; Kolodner RD
Proc Natl Acad Sci U S A; 2020 Aug; 117(32):19415-19424. PubMed ID: 32719125
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Flap Endonuclease 1 Correlates with Enhanced Proliferation and Poor Prognosis of Non-Small-Cell Lung Cancer.
Zhang K; Keymeulen S; Nelson R; Tong TR; Yuan YC; Yun X; Liu Z; Lopez J; Raz DJ; Kim JY
Am J Pathol; 2018 Jan; 188(1):242-251. PubMed ID: 29037854
[TBL] [Abstract][Full Text] [Related]
8. FEN1 inhibitor SC13 promotes CAR-T cells infiltration into solid tumours through cGAS-STING signalling pathway.
Dong Y; Wang Y; Yin X; Zhu H; Liu L; Zhang M; Chen J; Wang A; Huang T; Hu J; Liang J; Guo Z; He L
Immunology; 2023 Nov; 170(3):388-400. PubMed ID: 37501391
[TBL] [Abstract][Full Text] [Related]
9. Small molecule inhibitors uncover synthetic genetic interactions of human flap endonuclease 1 (FEN1) with DNA damage response genes.
Ward TA; McHugh PJ; Durant ST
PLoS One; 2017; 12(6):e0179278. PubMed ID: 28628639
[TBL] [Abstract][Full Text] [Related]
10. YY1 suppresses FEN1 over-expression and drug resistance in breast cancer.
Wang J; Zhou L; Li Z; Zhang T; Liu W; Liu Z; Yuan YC; Su F; Xu L; Wang Y; Zhou X; Xu H; Hua Y; Wang YJ; Zheng L; Teng YE; Shen B
BMC Cancer; 2015 Feb; 15():50. PubMed ID: 25885449
[TBL] [Abstract][Full Text] [Related]
11. Synergistic antitumor effect of combined paclitaxel with FEN1 inhibitor in cervical cancer cells.
He L; Yang H; Zhou S; Zhu H; Mao H; Ma Z; Wu T; Kumar AK; Kathera C; Janardhan A; Pan F; Hu Z; Yang Y; Luo L; Guo Z
DNA Repair (Amst); 2018 Mar; 63():1-9. PubMed ID: 29358095
[TBL] [Abstract][Full Text] [Related]
12. Jianpi-yangwei decoction inhibits DNA damage repair in the drug resistance of gastric cancer by reducing FEN1 expression.
Huang W; Tang H; Wen F; Lu X; Li Q; Shu P
BMC Complement Med Ther; 2020 Jun; 20(1):196. PubMed ID: 32586310
[TBL] [Abstract][Full Text] [Related]
13. FEN1 mediates miR-200a methylation and promotes breast cancer cell growth
Zeng X; Qu X; Zhao C; Xu L; Hou K; Liu Y; Zhang N; Feng J; Shi S; Zhang L; Xiao J; Guo Z; Teng Y; Che X
FASEB J; 2019 Oct; 33(10):10717-10730. PubMed ID: 31266372
[TBL] [Abstract][Full Text] [Related]
14. PRMT1 is critical to FEN1 expression and drug resistance in lung cancer cells.
He L; Hu Z; Sun Y; Zhang M; Zhu H; Jiang L; Zhang Q; Mu D; Zhang J; Gu L; Yang Y; Pan FY; Jia S; Guo Z
DNA Repair (Amst); 2020 Nov; 95():102953. PubMed ID: 32861926
[TBL] [Abstract][Full Text] [Related]
15. Flap endonuclease 1 is a promising candidate biomarker in gastric cancer and is involved in cell proliferation and apoptosis.
Wang K; Xie C; Chen D
Int J Mol Med; 2014 May; 33(5):1268-74. PubMed ID: 24590400
[TBL] [Abstract][Full Text] [Related]
16. MiR-26a-5p Heightens Breast Cancer Cell Sensitivity to Paclitaxel via Targeting Flap Endonuclease 1.
Cai Y; Zhang T; Chen G; Liu C
Ann Clin Lab Sci; 2023 Jan; 53(1):116-125. PubMed ID: 36889769
[TBL] [Abstract][Full Text] [Related]
17. FEN1 inhibitor increases sensitivity of radiotherapy in cervical cancer cells.
Li JL; Wang JP; Chang H; Deng SM; Du JH; Wang XX; Hu HJ; Li DY; Xu XB; Guo WQ; Song YH; Guo Z; Sun MX; Wu YW; Liu SB
Cancer Med; 2019 Dec; 8(18):7774-7780. PubMed ID: 31670906
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.
Xue D; Lu H; Xu HY; Zhou CX; He XZ
J Cell Mol Med; 2018 Jun; 22(6):3223-3237. PubMed ID: 29633510
[TBL] [Abstract][Full Text] [Related]
19. Targeting FEN1 Suppresses the Proliferation of Chronic Myeloid Leukemia Cells Through Regulating Alternative End-Joining Pathways.
Zhu Y; Dai H; Wang Y; Liang Y; Feng W; Yuan Y
DNA Cell Biol; 2021 Aug; 40(8):1101-1111. PubMed ID: 34156283
[TBL] [Abstract][Full Text] [Related]
20. FEN1 Inhibition as a Potential Novel Targeted Therapy against Breast Cancer and the Prognostic Relevance of FEN1.
Berfelde J; Hildebrand LS; Kuhlmann L; Fietkau R; Distel LV
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]